![]() |
|
|
Vol. 26, Issue 11, 1134-1143, November 1998
Departments of Medicinal Chemistry (MOJ, RC, VMKMJ) and
Pharmacodynamics (MJK), College of Pharmacy, and Department of
Medicine, Division of Endocrinology and Metabolism (ZY, GNH, ND, PWS),
Department of Health Policy and Epidemiology (BP), and Department of
Biochemistry and Molecular Biology (PWS), College of Medicine,
University of Florida
Pathways of metabolism of dichloroacetate (DCA), an investigational
drug for the treatment of lactic acidosis in humans and a rodent
hepatocarcinogen, are poorly understood. In this study, rats were
given, by gavage, one or two 50 mg/kg doses of NaDCA. DCA labeled with
14C (carboxy carbon) or
13C (both carbons) was used in studies of
disposition and pharmacokinetics, respectively. The effect of fasting
for 14 hr before dosing was studied. Expired air, urine, feces, and
tissues were collected from [14C]DCA-dosed
rats. Urine was analyzed by HPLC, GC/MS, and NMR spectroscopy. Plasma
samples were analyzed by GC/MS. DCA plasma elimination half-lives were
0.1 ± 0.02 and 5.4 ± 0.8 hr in young adult rats (180-265
g, 3-4 months of age) given one or two doses of DCA, respectively, and
9.7 ± 1 hr in large, 16-month-old rats given two DCA doses. The
percentage of the DCA dose excreted as CO2 varied from 17 to 46% and was lower (p < 0.001) in fed rats, compared with rats fasted overnight before dosing.
Urine contained DCA and DCA metabolites, including oxalate, glyoxylate,
and conjugated glycine (mainly hippurate and phenylacetylglycine). More
unchanged DCA was excreted by large rats pretreated with DCA (mean,
20.2% of the dose) than by young adult rats given one dose of DCA
(mean, 0.5%). This study confirmed that CO2,
glycine, and oxalate are major products of DCA metabolism, it
demonstrated that one dose of DCA altered the elimination of a
subsequent dose, and it showed that age or body size, as well as access
to food, significantly affected DCA metabolism in rats.
This article has been cited by other articles:
![]() |
A. L. Shroads, X. Guo, V. Dixit, H.-P. Liu, M. O. James, and P. W. Stacpoole Age-Dependent Kinetics and Metabolism of Dichloroacetate: Possible Relevance to Toxicity J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 1163 - 1171. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jia, B. Coats, M. Chadha, B. Frentzen, J. Perez-Rodriguez, P. A. Chadik, R. A. Yost, G. N. Henderson, and P. W. Stacpoole Human Kinetics of Orally and Intravenously Administered Low-Dose 1,2-13C-Dichloroacetate. J. Clin. Pharmacol., December 1, 2006; 46(12): 1449 - 1459. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Guo, V. Dixit, H. Liu, A. L. Shroads, G. N. Henderson, M. O. James, and P. W. Stacpoole INHIBITION AND RECOVERY OF RAT HEPATIC GLUTATHIONE S-TRANSFERASE ZETA AND ALTERATION OF TYROSINE METABOLISM FOLLOWING DICHLOROACETATE EXPOSURE AND WITHDRAWAL Drug Metab. Dispos., January 1, 2006; 34(1): 36 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. B. M. Lantum, R. B. Baggs, D. M. Krenitsky, and M. W. Anders Nephrotoxicity of Chlorofluoroacetic Acid in Rats Toxicol. Sci., December 1, 2002; 70(2): 261 - 268. [Abstract] [Full Text] [PDF] |
||||